Funds holding ArriVent Biopharma Inc
ISIN US04272N1028 · United States
- Fund holders
- 144
- Of which ETFs
- 37 107 other funds
- Value held
- 300M $
- Share of capital
- 18.7 % of 49.3M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 2,586 | 77.1K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 2,579 | 89.6K $ | 0.03 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,575 | 89.5K $ | 0.04 % | 0.01 % | as of Jun 30, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 2,435 | 84.6K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,201 | 66.6K $ | 0.10 % | 0.00 % | as of May 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 2,134 | 74.1K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 1,848 | 64.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 1,725 | 51.4K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 1,707 | 59.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,527 | 46.2K $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,517 | 45.9K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 1,457 | 43.4K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,327 | 46.1K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,242 | 37.6K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 1,208 | 36K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 1,200 | 36.3K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 1,187 | 35.9K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,100 | 38.2K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,051 | 31.8K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 957 | 33.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 881 | 26.3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 873 | 30.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 828 | 28.8K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 762 | 26.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 744 | 25.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 714 | 21.6K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 488 | 14.6K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 437 | 15.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 424 | 12.6K $ | 0.12 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Pacer WealthShield ETF Pacer Funds Trust | 407 | 12.1K $ | 0.05 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 360 | 12.5K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 233 | 6.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 210 | 7.3K $ | 0.13 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 204 | 7.1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 156 | 5.4K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 106 | 3.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 102 | 3.5K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 94 | 3.3K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 56 | 1.9K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 39 | 1.4K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 32 | 954.2 $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 30 | 908.1 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 382.1 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 10 | 302.7 $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.85 % | as of May 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.83 % | as of May 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 0.73 % | as of May 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.65 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 0.32 % | as of Jul 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.29 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.28 % | as of Jun 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.28 % | as of Jun 30, 2026 ↗ |
| NVIT GS Small Cap Equity Insights Fund Nationwide Variable Insurance Trust | 0.26 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 0.26 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 144 | +6 | 9,212,598 | +9.4 % |
| 2026Q2 | 138 | +14 | 8,420,250 | +4.6 % |
| 2026Q1 | 124 | +11 | 8,048,999 | +2.0 % |
| 2025Q4 | 113 | +4 | 7,892,971 | +33.9 % |
| 2025Q3 | 109 | -5 | 5,895,447 | -5.2 % |
| 2025Q2 | 114 | +11 | 6,219,152 | +0.6 % |
| 2025Q1 | 103 | +7 | 6,180,810 | +16.7 % |
| 2024Q4 | 96 | +18 | 5,297,585 | +55.8 % |
| 2024Q3 | 78 | +17 | 3,400,143 | +6.8 % |
| 2024Q2 | 61 | +59 | 3,183,900 | +212,160.0 % |
| 2024Q1 | 2 | 1,500 |
Institutional managers
131 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,401,083 | 101.5M $ | as of Mar 31, 2026 |
| INFINITUM ASSET MANAGEMENT, LLC | 4,148,923 | 95.7M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 3,929,117 | 90.6M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 3,027,328 | 69.8M $ | as of Mar 31, 2026 |
| FMR LLC | 3,016,132 | 69.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,530,301 | 58.4M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 1,971,054 | 45.5M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 1,942,142 | 44.8M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 1,696,752 | 39.1M $ | as of Mar 31, 2026 |
| General Catalyst Group Management, LLC | 1,494,786 | 34.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,421,415 | 32.8M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 885,916 | 20.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 853,427 | 19.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 803,652 | 18.5M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 748,195 | 17.3M $ | as of Mar 31, 2026 |
| HSG Holding Ltd | 663,308 | 14M $ | as of Mar 31, 2026 |
| Fund 1 Investments, LLC | 499,990 | 11.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 486,263 | 11.2M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 426,281 | 9.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 425,923 | 9.8M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 368,795 | 8.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 350,000 | 8.1M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 268,812 | 6.2M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 258,772 | 6M $ | as of Mar 31, 2026 |
| NOMURA HOLDINGS INC | 242,050 | 5.6M $ | as of Mar 31, 2026 |
Declared shareholders of ArriVent Biopharma Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BlackRock, Inc. | 6.80 % | 3,182,080 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ArriVent Biopharma Inc". https://titelia.com/en/stocks/arrivent-biopharma-inc-US04272N1028